Francesco Ferraù

First demonstration of the effectiveness of peptide receptor radionuclide therapy (PRRT) with 111In-DTPA-octreotide in a giant PRL-secreting pituitary adenoma resistant to conventional treatment

F. Trimarchi, S. Cannavò, F. Granata, 2012, Pituitary.

Acromegaly, genetic variants of the aryl hydrocarbon receptor pathway and environmental burden

F. Trimarchi, S. Cannavò, F. Ferraù, 2017, Molecular and Cellular Endocrinology.

Increased prevalence of restless legs syndrome in patients with acromegaly and effects on quality of life assessed by Acro-QoL

M. Ragonese, A. Alibrandi, G. Romanello, 2011, Pituitary.